EUVIMEDEUVIMED entdecken
Open Access

Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis

Xiangxiang Wang, Shuang Li, Jinmiao Liu, Wenying Sun, Han Zhao, Qing Han, Yijia Liu, Xiaolin Cao, Qianhui Li, Yuhan Jin, Xiaochen Guo, Guiping Ren

Naunyn-Schmiedeberg's Archives of Pharmacology · 2023

DOI: 10.1007/s00210-023-02540-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2023. Verfasst von Xiangxiang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, 600 Changjiang Road, Harbin, 150030, China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, “Young Talents” Project of Northeast Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis is a progressive and fatal fibrotic lung disease and associated with a high mortality rate. In the study, the prevention and treatment effects of fibroblast growth factor-21 (FGF-21) in bleomycin (BLM)-induced pulmonary fibrosis were investigated in vivo and vitro. In the prevention of pulmonary fibrosis studies, the results showed that interdict of FGF-21 could reduce the related gene and protein expression levels of pulmonary fibrosis. In addition, FGF-21 significantly reduced both the aggregation of inflammatory cells and deposition of collagen in the lung by histopathology. In therapy of pulmonary fibrosis studies, the results indicated that treatment with FGF-21 resulted in an amelioration of the pulmonary fibrosis in mice with reductions of the pathological score, collagen deposition and transforming growth factor (TGF)-β and α-smooth muscle actin (α-SMA) expressions in the lung tissues at fibrotic stage, and late administration was also able to reduce the degree of pulmonary fibrosis and even better than these in the prevention group. Furthermore, BLM-induced THP-1 macrophage model was verified using FGF-21; the result showed that FGF-21 decreased the related gene expression level of pulmonary fibrosis. FGF-21 may have preventive and therapeutic effects on BLM-induced pulmonary fibrosis via inhibiting myofibroblast differentiation and inflammatory. Thus, FGF-21 represents a potential drug for the prevention and treatment of pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisMiceAnimalsBleomycinFibroblastsLungFibroblast Growth FactorsTransforming Growth Factor betaFibrosisCollagenTransforming Growth Factor beta1Mice, Inbred C57BL

Stichwörter der Autor:innen

Fibroblast growth factor-21Inflammatory responsePulmonary fibrosisTGF-βα-SMA

Substanzen

Bleomycinfibroblast growth factor 21Fibroblast Growth FactorsTransforming Growth Factor betaCollagenTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, 600 Changjiang Road, Harbin, 150030, China.
  • Institute of Microbiology, Heilongjiang Academy of Sciences, Harbin, 150010, China.
  • Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, 600 Changjiang Road, Harbin, 150030, China. 676553202@qq.com.
  • Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, 600 Changjiang Road, Harbin, 150030, China. renguiping@126.com.
  • Research Center of Genetic Engineering of Pharmaceuticals of Heilongjiang Province, Northeast Agricultural University, Harbin, 150030, China. renguiping@126.com.
  • Key Laboratory of Agricultural Biological Functional Gene, Northeast Agricultural University, Harbin, 150030, China. renguiping@126.com.

Förderung

  • National Natural Science Foundation of China
  • “Young Talents” Project of Northeast Agricultural University

Zitieren

APA

Wang, X., Li, S., Liu, J., Sun, W., Zhao, H., Han, Q., Liu, Y., Cao, X., Li, Q., Jin, Y., Guo, X., & Ren, G. (2023). Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02540-3

Vancouver

Wang X, Li S, Liu J, Sun W, Zhao H, Han Q, et al. Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023. doi:10.1007/s00210-023-02540-3

BibTeX
@article{Wang2023,
  author = {Wang, Xiangxiang and Li, Shuang and Liu, Jinmiao and Sun, Wenying and Zhao, Han and Han, Qing and Liu, Yijia and Cao, Xiaolin and Li, Qianhui and Jin, Yuhan and Guo, Xiaochen and Ren, Guiping},
  title = {Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2023},
  doi = {10.1007/s00210-023-02540-3}
}
Kostenlos starten →